Study Objectives

    • Determine how long after infection people shed COVID-19 virus, including live virus, which suggests they may still be contagious

    • Compare how novel variants affect the duration of viral shedding

    • Determine how COVID-19 treatments, such as monoclonal antibodies and nirmatrelvir-ritonavir (Paxlovid) affect shedding of the virus

    • Determine how the immune system affects duration of viral shedding, particularly among people with immune system disorders or those on immunosuppressive therapies

    • Measure if and how often the SARS-CoV-2 virus mutates among people on treatment for COVID-19 or with prolonged infection due to immune deficiencies